• $325.9M
    Market Cap
  • 17.74%
    1-Year Change
  • Biotechnology
    Industry
Annual
Quarterly
12/31/2025
12/31/2024
12/31/2023
12/31/2022
Income Statement
Total Operating Revenue
559,000
-98.71%
43.3M
+70.47%
25.4M
+44.99%
17.5M
+40.97%
Cost of Revenue
215,000
-98.18%
11.8M
+14.46%
10.3M
-5.17%
10.9M
+45.92%
Gross Profit
344,000
-98.91%
31.4M
+108.86%
15.1M
+127.41%
6.6M
+33.51%
Sales and Marketing Expense
44.9M
+4.59%
42.9M
N/A
N/A
N/A
N/A
N/A
Research and Development Expense
-67.8M
-0.19%
-67.9M
+54.19%
-44.0M
+23.65%
-35.6M
+15.73%
Depreciation and Amortization Expense
312,000
-7.14%
336,000
N/A
N/A
N/A
N/A
N/A
Total Operating Expenses
215,000
-98.18%
11.8M
-42.77%
20.6M
+5.24%
19.6M
-1.99%
Operating Profit
-91.1M
+43.84%
-63.3M
+27.65%
-49.6M
+2.08%
-48.6M
+6.07%
Interest Income
3.5M
-22.18%
4.5M
N/A
N/A
N/A
N/A
N/A
Interest Expense
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Interest Income and Expense and Net
3.5M
-22.18%
4.5M
N/A
0
N/A
0
N/A
Total Nonoperating Income and Expense
3.5M
-22.18%
4.5M
N/A
N/A
N/A
N/A
N/A
Income before Taxes
-88.6M
+99.26%
-44.5M
+2.77%
-43.3M
+6.86%
-40.5M
+2.74%
Income Taxes
11,000
-98.70%
845,000
+112.00%
-7.0M
+2.38%
-6.9M
+6.72%
Extraordinary Items
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Net Income
-88.6M
+95.57%
-45.3M
+4.72%
-43.3M
+6.86%
-40.5M
+2.74%
Net Income from Continuing Operations Applicable to Common
-88.6M
+99.26%
-44.5M
+2.77%
-43.3M
+6.86%
-40.5M
+2.74%
Basic EPS and Net Income
-0.63
+90.91%
-0.33
N/A
N/A
N/A
N/A
N/A
Diluted EPS and Net Income
-0.63
+90.91%
-0.33
N/A
N/A
N/A
N/A
N/A
Basic Weighted Average Shares
141.7M
+2.12%
138.8M
+24.69%
111.3M
+15.21%
96.6M
+8.58%
Diluted Weighted Average Shares
141.7M
+2.12%
138.8M
+24.69%
111.3M
+15.21%
96.6M
+8.58%
Balance Sheet
Cash and Cash Equivalents
11.3M
-90.71%
121.3M
+124.56%
54.0M
-1.43%
54.8M
-25.46%
Short-Term Investments
73.8M
+183.94%
26.0M
N/A
N/A
N/A
N/A
N/A
Cash and Cash Equivalents and Short-Term Investments
85.1M
-42.23%
147.3M
+172.68%
54.0M
-1.43%
54.8M
-25.46%
Total Current Assets
118.7M
-36.67%
187.4M
+131.26%
81.0M
-16.20%
96.7M
+11.99%
Accumulated Depreciation
4.0M
-12.46%
4.5M
N/A
N/A
N/A
N/A
N/A
Property and Plant and Equipment and Net
1.6M
-13.04%
1.8M
+0.28%
1.8M
-17.63%
2.2M
+13.22%
Total Long-Term Assets
127,000
-96.46%
3.6M
-71.96%
12.8M
+18.37%
10.8M
+9.66%
Total Assets
131.4M
-35.13%
202.6M
N/A
N/A
N/A
N/A
N/A
Income Taxes Payable
39,000
-94.02%
652,000
N/A
N/A
N/A
N/A
N/A
Total Short-Term Debt
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Current Liabilities
13.6M
-19.08%
16.8M
-5.33%
17.8M
-19.02%
21.9M
+44.68%
Total Long-Term Debt
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Long-Term Liabilities
55.5M
+6.97%
51.9M
-12.02%
59.0M
-7.06%
63.5M
-12.44%
Total Liabilities
69.1M
+0.77%
68.6M
N/A
N/A
N/A
N/A
N/A
Retained Earnings
-562.6M
+18.68%
-474.0M
+55.62%
-304.6M
+15.71%
-263.3M
+18.07%
Total Stockholders Equity
62.3M
-53.51%
134.0M
+686.06%
17.1M
-22.75%
22.1M
+158.88%
Total Shares Outstanding
141.7M
+0.02%
141.7M
N/A
N/A
N/A
N/A
N/A
Cash Flow
Cash from Operating Activities
-62.3M
-7.94%
-67.6M
+71.89%
-39.4M
-13.43%
-45.5M
-767.88%
Capital Expenditures
55,000
-73.93%
211,000
N/A
N/A
N/A
N/A
N/A
Cash from Investing Activities
-48.0M
+118.48%
-22.0M
-233.69%
16.4M
+199.32%
-16.5M
-290.66%
Dividends Paid
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash from Financing Activities
15,000
-99.99%
142.1M
+464.85%
25.2M
-41.57%
43.0M
+40.17%
Financials Ratio
Gross Margin
61.54%
-15.35%
72.70%
+22.52%
59.34%
+56.85%
37.83%
-5.29%
Operating Margin
-16,292.84%
+11,030.88%
-146.38%
-25.12%
-195.48%
-29.60%
-277.66%
-24.76%
Return on Assets
-53.05%
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Return on Equity
-90.27%
+50.49%
-59.98%
-72.88%
-221.19%
-16.42%
-264.65%
-40.96%
Revenue Growth
-98.71%
-240.06%
70.47%
+56.64%
44.99%
+9.83%
40.97%
-67.64%
Current Ratio
8.72
-21.74%
11.14
+144.27%
4.56
+3.48%
4.41
-22.59%
Cash Ratio
0.83
-88.51%
7.21
+137.20%
3.04
+21.72%
2.50
-48.48%
Debt-to-Equity Ratio
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Debt-to-Assets Ratio
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A

Earnings & Revenue History

Debt-to-Assets

Cash Flow